
[BNews]
Current Articles
What Investors Should Know About a $511K Disc Medicine Insider Sale and a 26% Stock Run
This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance. On Jan. 2, Rahul Khara, the chief legal officer of Disc Medicine (IRON 1.45%), exercised and immediately sold 6,500 shares in a derivative transaction valued at approximately $511,472, according to an SEC Form 4 filing. Transaction summary Metric...
Vitalik Reveals Ethereum Is Now Positioned Against What Crypto VCs Actually Want To Fund
Buterin says Ethereum tripling down on sovereign individuals vs custodial stables, centralized DeFi, yield products. Oracle capture and governance extraction criticized.
Will MetLife’s (MET) New MIM Segment and Capital Returns Reshape Its Core Investment Narra
In early January 2026, MetLife, Inc. confirmed a first-quarter 2026 common stock dividend of US$0.5675 per share and outlined plans for continued buybacks alongside a restructuring that makes MetLife Investment Management a standalone reportable segment under updated asset-management fee arrangements. This combination of segment reorganization and ongoing capital returns highlights MetLife’s emphasis on growing its...




